ALEMBIC PHARMACEUTICALS
Back to Cashflow Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹444 Cr | ₹-438 Cr | ₹-262 Cr | ₹-217 Cr | ₹-597 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹444 Cr |
| Mar2024 | ₹-438 Cr |
| Mar2023 | ₹-262 Cr |
| Mar2022 | ₹-217 Cr |
| Mar2021 | ₹-597 Cr |
How is Cash Flow from Financing Activities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹444 Cr | Positive | |
| Mar2024 | ₹-438 Cr | Negative | |
| Mar2023 | ₹-262 Cr | Negative | |
| Mar2022 | ₹-217 Cr | Negative | |
| Mar2021 | ₹-597 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹13,790.5 Cr | -1.3% | -12.5% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -1.3% |
-12.5% |
-12.9% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses